These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
201 related articles for article (PubMed ID: 29931682)
21. Lipoplexes targeting the CD44 hyaluronic acid receptor for efficient transfection of breast cancer cells. Surace C; Arpicco S; Dufaÿ-Wojcicki A; Marsaud V; Bouclier C; Clay D; Cattel L; Renoir JM; Fattal E Mol Pharm; 2009; 6(4):1062-73. PubMed ID: 19413341 [TBL] [Abstract][Full Text] [Related]
22. Protamine/DNA/Niosome Ternary Nonviral Vectors for Gene Delivery to the Retina: The Role of Protamine. Puras G; Martínez-Navarrete G; Mashal M; Zárate J; Agirre M; Ojeda E; Grijalvo S; Eritja R; Diaz-Tahoces A; Avilés-Trigueros M; Fernández E; Pedraz JL Mol Pharm; 2015 Oct; 12(10):3658-71. PubMed ID: 26334586 [TBL] [Abstract][Full Text] [Related]
23. Optimization of lipid composition in cationic emulsion as in vitro and in vivo transfection agents. Kim TW; Chung H; Kwon IC; Sung HC; Jeong SY Pharm Res; 2001 Jan; 18(1):54-60. PubMed ID: 11336353 [TBL] [Abstract][Full Text] [Related]
24. Cationic liposomes produced via ethanol injection method for dendritic cell therapy. Vitor MT; Bergami-Santos PC; Zômpero RHF; Cruz KSP; Pinho MP; Barbuto JAM; de la Torre LG J Liposome Res; 2017 Dec; 27(4):249-263. PubMed ID: 27386901 [TBL] [Abstract][Full Text] [Related]
25. Enhanced gene delivery efficiency of cationic liposomes coated with PEGylated hyaluronic acid for anti P-glycoprotein siRNA: a potential candidate for overcoming multi-drug resistance. Ran R; Liu Y; Gao H; Kuang Q; Zhang Q; Tang J; Huang K; Chen X; Zhang Z; He Q Int J Pharm; 2014 Dec; 477(1-2):590-600. PubMed ID: 25448564 [TBL] [Abstract][Full Text] [Related]
26. Properties of cationic liposomes composed of cationic lipid YKS-220 having an ester linkage: adequate stability, high transfection efficiency, and low cytotoxicity. Obika S; Yu W; Shimoyama A; Uneda T; Minami T; Miyashita K; Doi T; Imanishi T Biol Pharm Bull; 1999 Feb; 22(2):187-90. PubMed ID: 10077439 [TBL] [Abstract][Full Text] [Related]
29. Characterization and in vivo performance of dextran-spermine polyplexes and DOTAP/cholesterol lipoplexes administered locally and systemically. Eliyahu H; Joseph A; Schillemans JP; Azzam T; Domb AJ; Barenholz Y Biomaterials; 2007 May; 28(14):2339-49. PubMed ID: 17298842 [TBL] [Abstract][Full Text] [Related]
30. Development and characterization of a novel cationic PEGylated niosome-encapsulated forms of doxorubicin, quercetin and siRNA for the treatment of cancer by using combination therapy. Hemati M; Haghiralsadat F; Yazdian F; Jafari F; Moradi A; Malekpour-Dehkordi Z Artif Cells Nanomed Biotechnol; 2019 Dec; 47(1):1295-1311. PubMed ID: 30033768 [TBL] [Abstract][Full Text] [Related]
31. Nonionic surfactant vesicles composed of novel spermine-derivative cationic lipids as an effective gene carrier in vitro. Paecharoenchai O; Niyomtham N; Leksantikul L; Ngawhirunpat T; Rojanarata T; Yingyongnarongkul BE; Opanasopit P AAPS PharmSciTech; 2014 Jun; 15(3):722-30. PubMed ID: 24623349 [TBL] [Abstract][Full Text] [Related]
32. Electroporation-enhanced gene delivery in mammary tumors. Wells JM; Li LH; Sen A; Jahreis GP; Hui SW Gene Ther; 2000 Apr; 7(7):541-7. PubMed ID: 10819568 [TBL] [Abstract][Full Text] [Related]
33. Non-viral vectors based on cationic niosomes as efficient gene delivery vehicles to central nervous system cells into the brain. Mashal M; Attia N; Soto-Sánchez C; Martínez-Navarrete G; Fernández E; Puras G; Pedraz JL Int J Pharm; 2018 Dec; 552(1-2):48-55. PubMed ID: 30244145 [TBL] [Abstract][Full Text] [Related]
34. Coating nanocarriers with hyaluronic acid facilitates intravitreal drug delivery for retinal gene therapy. Martens TF; Remaut K; Deschout H; Engbersen JF; Hennink WE; van Steenbergen MJ; Demeester J; De Smedt SC; Braeckmans K J Control Release; 2015 Mar; 202():83-92. PubMed ID: 25634806 [TBL] [Abstract][Full Text] [Related]
35. Hyaluronic acid-coated niosomes facilitate tacrolimus ocular delivery: Mucoadhesion, precorneal retention, aqueous humor pharmacokinetics, and transcorneal permeability. Zeng W; Li Q; Wan T; Liu C; Pan W; Wu Z; Zhang G; Pan J; Qin M; Lin Y; Wu C; Xu Y Colloids Surf B Biointerfaces; 2016 May; 141():28-35. PubMed ID: 26820107 [TBL] [Abstract][Full Text] [Related]
36. In vivo targeted gene delivery by cationic nanoparticles for treatment of hepatocellular carcinoma. Díez S; Navarro G; de ILarduya CT J Gene Med; 2009 Jan; 11(1):38-45. PubMed ID: 19021130 [TBL] [Abstract][Full Text] [Related]
37. Modulation of cellular immune response against hepatitis C virus nonstructural protein 3 by cationic liposome encapsulated DNA immunization. Jiao X; Wang RY; Feng Z; Alter HJ; Shih JW Hepatology; 2003 Feb; 37(2):452-60. PubMed ID: 12540796 [TBL] [Abstract][Full Text] [Related]
38. Evaluation of cationic dendrimer and lipid as transfection reagents of short RNAs for stem cell modification. Ziraksaz Z; Nomani A; Soleimani M; Bakhshandeh B; Arefian E; Haririan I; Tabbakhian M Int J Pharm; 2013 May; 448(1):231-8. PubMed ID: 23535347 [TBL] [Abstract][Full Text] [Related]
39. Drug-fortified liposomes as carriers for sustained release of NSAIDs: The concept and its validation in the animal model for the treatment of arthritis. Pawar VA; Manjappa AS; Murumkar PR; Gajaria TK; Devkar RV; Mishra AK; Yadav MR Eur J Pharm Sci; 2018 Dec; 125():11-22. PubMed ID: 30219410 [TBL] [Abstract][Full Text] [Related]
40. The biological activity of cationic liposomes in drug delivery and toxicity test in animal models. Qi P; Cao M; Song L; Chen C; Liu M; Li N; Wu D; Peng J; Hu G; Zhao J Environ Toxicol Pharmacol; 2016 Oct; 47():159-164. PubMed ID: 27694054 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]